| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.55M | 1.32M | 683.00K | 1.19M | 1.28M | 1.15M |
| Gross Profit | 1.20M | 1.08M | 585.00K | 1.25M | 1.20M | 1.11M |
| EBITDA | 1.05M | 640.00K | 1.40M | 1.28M | 762.00K | 624.00K |
| Net Income | 1.33M | 1.36M | 1.07M | 1.11M | 2.41M | 1.08M |
Balance Sheet | ||||||
| Total Assets | 31.75M | 31.71M | 31.43M | 30.92M | 30.96M | 29.66M |
| Cash, Cash Equivalents and Short-Term Investments | 14.87M | 14.53M | 12.25M | 10.79M | 8.95M | 5.50M |
| Total Debt | 146.00K | 150.00K | 158.00K | 165.00K | 172.00K | 178.00K |
| Total Liabilities | 1.07M | 1.05M | 1.00M | 944.00K | 1.14M | 1.21M |
| Stockholders Equity | 30.68M | 30.66M | 30.42M | 29.98M | 29.81M | 28.44M |
Cash Flow | ||||||
| Free Cash Flow | -1.42M | 793.00K | 379.00K | 283.00K | 3.39M | 1.40M |
| Operating Cash Flow | -553.00K | 794.00K | 381.00K | 283.00K | 3.42M | 1.45M |
| Investing Cash Flow | 3.93M | 8.80M | 1.83M | -3.87M | -1.09M | 89.00K |
| Financing Cash Flow | -1.19M | -1.12M | -603.00K | -918.00K | -1.01M | -1.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £21.07M | 5.00 | 5.05% | ― | -7.14% | ― | |
69 Neutral | £27.29M | 12.00 | 4.44% | 0.91% | 3.71% | 29.79% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | £49.32M | 11.84 | 6.10% | 3.92% | -4.65% | -36.18% | |
56 Neutral | £162.53M | 114.91 | -2.38% | ― | ― | ― | |
50 Neutral | £30.58M | -0.36 | -27.53% | ― | 15.55% | -116.52% | |
47 Neutral | £41.16M | -26.19 | -1.96% | ― | ― | ― |